GO:0019838 growth factor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019838 growth factor binding is a molecular function defined as binding to a growth factor, a protein or polypeptide that stimulates a cell or organism to grow or proliferate [QuickGO].
• Growth factor binding proteins such as FGF-BP, HB-EGF, and HDGF modulate the availability, localization, and activity of growth factors in development, tissue repair, and cancer [1,3,6].
• Dysregulated growth factor binding contributes to squamous cell carcinoma, hematological malignancies, and impaired musculoskeletal repair [5,7,8].
• Experimental models for studying growth factor binding include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening [4,8].
• Key methods to interrogate growth factor binding include surface plasmon resonance, co-immunoprecipitation, and functional proliferation assays [2,4].
• Targeting growth factor binding proteins, such as FGF-BP with vitamin D3 or eldecalcitol, represents a potential therapeutic strategy in squamous cell carcinoma.
Description
Growth factor binding (GO:0019838) is a molecular function that enables a protein or polypeptide to physically interact with a growth factor, thereby influencing cell growth and proliferation [QuickGO]. Growth factors are signaling molecules that stimulate cellular division, differentiation, and survival, and their binding partners often act as carriers, co-receptors, or modulators that determine when, where, and how strongly a growth factor signal is delivered [1,3,6]. The importance of this function is underscored by its roles in tissue repair, where improved growth-factor binding can enhance regenerative outcomes, and in cancer, where aberrant growth factor binding drives tumor progression [5,7]. Researchers study growth factor binding to understand fundamental signaling mechanisms and to develop targeted therapies for diseases ranging from squamous cell carcinoma to hematological malignancies [5,7,8].
growth factor binding At A Glance
| GO ID | GO:0019838 |
|---|---|
| GO term | growth factor binding |
| Ontology | molecular_function |
| Synonym | neurotrophin TRK receptor activity |
| Definition | Binding to a growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate. |
| Major function | Mediates physical interaction with growth factors to regulate cell growth and proliferation. |
| Examples | FGF-BP, HB-EGF, HDGF, and other growth factor binding proteins. |
| Related diseases | Squamous cell carcinoma, hematological malignancies, musculoskeletal disorders. |
What Is GO:0019838?
According to the Gene Ontology, growth factor binding (GO:0019838) is the binding to a growth factor, which is defined as proteins or polypeptides that stimulate a cell or organism to grow or proliferate [QuickGO]. This molecular function encompasses interactions between a binding protein and a growth factor ligand, such as fibroblast growth factors, epidermal growth factor-like ligands, or hepatoma-derived growth factor [1,2,3]. The synonym neurotrophin TRK receptor activity reflects historical annotations linking this term to neurotrophin signaling, although the core definition centers on growth factor binding [QuickGO].
Why Is growth factor binding Important in Cell Biology?
Growth factor binding is a central node in cell signaling because it determines the bioavailability and activity of growth factors, which are critical for normal development, tissue homeostasis, and repair [1,4,6]. Dysregulation of this function can lead to uncontrolled proliferation in cancer or impaired regeneration in degenerative conditions [5,7,8]. Understanding the molecular details of growth factor binding enables the design of biologics and small molecules that modulate these interactions for therapeutic benefit [4,5].
• Regulates the spatial and temporal availability of growth factors to their receptors [1,6].
• Plays a key role in tissue repair and regeneration, as enhanced growth-factor binding can improve outcomes.
• Contributes to cancer progression when growth factor binding proteins are overexpressed or dysregulated [5,7].
• Influences hematopoiesis and immune cell development through HB-EGF/diphtheria toxin receptor interactions.
• Provides targets for therapeutic intervention, such as FGF-BP inhibition in squamous cell carcinoma.
• Is essential for musculoskeletal development and repair, with immobilization strategies exploiting growth factor binding.
• Helps explain the mechanism of action of growth factor mimetics and antagonists.
• Serves as a biomarker for certain cancers and proliferative disorders [5,7].
• Enables the design of biomaterials that sequester and deliver growth factors for regenerative medicine.
• Facilitates the study of evolutionary conserved signaling pathways across species [1,6].
What Happens During growth factor binding?
Growth factor recognition and binding
In simple terms: A binding protein grabs onto a growth factor like a hand holding a key.
Growth factor binding proteins contain specific domains, such as heparin-binding motifs, that recognize and interact with growth factors like HB-EGF or FGFs [1,3,6]. This interaction can occur at the cell surface, in the extracellular matrix, or in the pericellular space, and it often involves electrostatic interactions with heparan sulfate proteoglycans [1,6].
Modulation of growth factor signaling
In simple terms: The binding protein can either help or hinder the growth factor's ability to send signals.
Once bound, the growth factor binding protein can either present the growth factor to its receptor, enhancing signaling, or sequester it away from the receptor, inhibiting signaling [3,6]. For example, FGF-BP can mobilize FGFs from the extracellular matrix and facilitate their binding to FGFRs, thereby promoting proliferation.
Juxtacrine and paracrine actions
In simple terms: Some growth factors act on the cell that makes them or on neighboring cells.
HB-EGF is a juxtacrine growth factor that remains membrane-bound and signals to adjacent cells, a process dependent on its binding to specific partners. This mode of action is critical in tissues where cell-cell contact regulates growth, such as in the skin and intestinal epithelium.
Intracellular trafficking and nuclear roles
In simple terms: Some growth factor binding proteins travel into the cell and even to the nucleus.
Hepatoma-derived growth factor (HDGF) can bind to proteins like SMYD1, and this interaction may influence its intracellular localization and function. Such nuclear roles expand the functional repertoire of growth factor binding beyond extracellular signaling.
Key Genes Involved in GO:0019838 growth factor binding
The following genes and proteins are representative examples of growth factor binding function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF-BP (FGFBP1) | Binds and mobilizes fibroblast growth factors | Target in squamous cell carcinoma; potential therapeutic intervention [3,5] |
| HB-EGF | Juxtacrine growth factor binding to EGFR/ErbB receptors | Role in hematopoiesis and cancer; diphtheria toxin receptor [6,7] |
| HDGF | Hepatoma-derived growth factor binding to SMYD1 | Implicated in cancer and transcriptional regulation |
| SMYD1 | Binds HDGF; histone methyltransferase | Muscle development and cancer |
| FGFR1 | Receptor for FGFs; interacts with FGF-BP | Development and cancer |
| EGFR | Receptor for HB-EGF | Cancer and tissue repair |
| ErbB4 | Receptor for HB-EGF | Hematopoiesis and cancer |
| Heparin-binding proteins | Bind growth factors via heparin motifs | Modulate growth factor activity |
| Diphtheria toxin receptor | HB-EGF-related; binds diphtheria toxin | Hematological malignancies |
| FGF2 | Fibroblast growth factor 2 | Angiogenesis and tissue repair |
| FGF7 | Fibroblast growth factor 7 | Epithelial repair |
| VEGF | Vascular endothelial growth factor | Angiogenesis; binding proteins modulate activity |
| IGF1 | Insulin-like growth factor 1 | Growth and metabolism |
| IGFBP3 | IGF binding protein 3 | Modulates IGF1 availability |
| TGF-beta | Transforming growth factor beta | Fibrosis and cancer |
| BMP2 | Bone morphogenetic protein 2 | Bone repair; binding proteins regulate activity |
| PDGF | Platelet-derived growth factor | Wound healing |
| NGF | Nerve growth factor | Neurotrophin signaling; TRK receptor activity [QuickGO] |
How Is growth factor binding Regulated?
Growth factor binding is regulated at multiple levels, including the expression levels of binding proteins, post-translational modifications such as glycosylation, and proteolytic cleavage that releases soluble ectodomains [1,6]. For example, HB-EGF is synthesized as a membrane-bound precursor that can be cleaved by metalloproteases to release soluble HB-EGF, which then binds to receptors. Additionally, the interaction between FGF-BP and FGFs is modulated by heparin and heparan sulfate, which can enhance or inhibit binding. In cancer, overexpression of FGF-BP increases the bioavailability of FGFs, promoting tumor growth.
growth factor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF-BP | Squamous cell carcinoma | Knockout and overexpression in SCC cell lines |
| HB-EGF | Hematological malignancies | Conditional knockout mouse models |
| HDGF | Cancer and transcriptional regulation | Point mutation of SMYD1 binding interface |
| IGFBP3 | Musculoskeletal disorders | Knock-in of binding-deficient mutants |
| EGFR | Cancer and tissue repair | CRISPR knockout in epithelial cells |
Squamous cell carcinoma
FGF-BP is overexpressed in squamous cell carcinoma and promotes tumor growth by mobilizing FGFs. Targeting FGF-BP with vitamin D3 or eldecalcitol reduces tumor cell proliferation, suggesting a therapeutic strategy.
Hematological malignancies
HB-EGF and its receptor ErbB4 are involved in normal and neoplastic hematopoiesis, and dysregulated HB-EGF signaling contributes to leukemia and lymphoma.
Musculoskeletal disorders
Growth factor binding is critical for bone and cartilage repair; immobilization strategies that enhance growth factor binding improve tissue regeneration in musculoskeletal disorders.
Tissue repair and regeneration
Improved growth-factor binding aids tissue repair, as demonstrated by engineered biomaterials that sequester and present growth factors to cells.
From growth factor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FGF-BP reduce tumor growth? | FGF-BP knockout in squamous cell carcinoma cell lines |
| How does HDGF binding to SMYD1 affect transcription? | Point mutation of HDGF binding residues |
| Can enhanced growth factor binding improve bone repair? | Knock-in of high-affinity binding variants in mesenchymal stem cells |
| What is the role of HB-EGF in hematopoiesis? | Conditional knockout of HB-EGF in hematopoietic stem cells |
| Does overexpression of FGF-BP drive proliferation? | Overexpression of FGF-BP in epithelial cells |
| Can CRISPR screening identify novel growth factor binding regulators? | Genome-wide CRISPR knockout library in cancer cells |
How to Study the growth factor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Characterizing growth factor-protein interactions |
| Co-immunoprecipitation | Protein-protein interactions | Identifying novel growth factor binding partners |
| Proliferation assay | Cell growth | Assessing functional effects of growth factor binding |
| CRISPR knockout screen | Gene essentiality and regulators | Discovering modifiers of growth factor binding |
| Western blot | Protein expression and phosphorylation | Validating signaling changes |
| Immunofluorescence | Subcellular localization | Visualizing growth factor binding in cells |
| ELISA | Quantification of growth factors | Measuring secreted growth factor levels |
| RNA-seq | Transcriptional changes | Identifying downstream targets of growth factor binding |
Surface plasmon resonance (SPR)
SPR measures real-time binding kinetics between growth factors and their binding proteins, providing quantitative affinity constants.
Co-immunoprecipitation (Co-IP)
Co-IP followed by mass spectrometry identifies endogenous protein complexes involving growth factors and their binding partners.
Cell proliferation assays
Proliferation assays, such as MTT or BrdU incorporation, measure the functional impact of growth factor binding on cell growth.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate growth factor binding and downstream signaling.
How CRISPR Can Be Used to Study GO:0019838 growth factor binding
Knockout
CRISPR knockout of growth factor binding proteins such as FGF-BP or HB-EGF can abolish their function, revealing their role in proliferation and survival [5,7]. For example, FGF-BP knockout in squamous cell carcinoma cells reduces tumor growth.
Point Mutation
Point mutations can be introduced into the binding interface of growth factor binding proteins to dissect specific residues required for interaction, as shown for HDGF binding to SMYD1.
Knock-in
Knock-in of tagged or high-affinity variants of growth factor binding proteins allows for tracking and enhanced function, useful in regenerative models.
Overexpression
Overexpression of growth factor binding proteins like FGF-BP can mimic cancer-associated upregulation and drive proliferation, providing a model for therapeutic testing [3,5].
How EDITGENE Supports growth factor binding Research
Researchers studying growth factor binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of growth factor binding proteins and their partners.
Contact EDITGENE today to design your custom CRISPR model for growth factor binding research.
Frequently Asked Questions About growth factor binding
What is growth factor binding?
Growth factor binding (GO:0019838) is a molecular function defined as binding to a growth factor, which is a protein or polypeptide that stimulates cell growth or proliferation [QuickGO].
What genes are involved in growth factor binding?
Key genes include FGF-BP, HB-EGF, HDGF, and their receptors such as FGFR1 and EGFR [1,2,3,6].
How does growth factor binding affect cancer?
Dysregulated growth factor binding can promote tumor growth, as seen with FGF-BP overexpression in squamous cell carcinoma.
What diseases are associated with growth factor binding?
Diseases include squamous cell carcinoma, hematological malignancies, and musculoskeletal disorders [5,7,8].
What methods are used to study growth factor binding?
Common methods include surface plasmon resonance, co-immunoprecipitation, and cell proliferation assays [2,5].
Can CRISPR be used to study growth factor binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect growth factor binding function [4,5,8].
What is the role of HB-EGF in hematopoiesis?
HB-EGF is a juxtacrine growth factor that regulates normal and neoplastic hematopoiesis through binding to ErbB receptors.
How is growth factor binding regulated?
It is regulated by expression levels, proteolytic cleavage, and interactions with heparan sulfate proteoglycans [1,6].
What is the synonym for GO:0019838?
The synonym is neurotrophin TRK receptor activity [QuickGO].
Why is growth factor binding important for tissue repair?
Enhanced growth factor binding can improve tissue regeneration by presenting growth factors to target cells [4,8].
Conclusion
Growth factor binding (GO:0019838) is a fundamental molecular function that governs how growth factors interact with their binding partners to control cell growth, proliferation, and tissue repair [1,4,6]. Its dysregulation is implicated in cancer and other diseases, making it a compelling target for therapeutic intervention [5,7,8]. Advances in CRISPR-based models and binding assays continue to unravel the complexities of this function, offering new opportunities for drug discovery and regenerative medicine [2,4,8].
References
- 1. Raab G et al.. 1997. Heparin-binding EGF-like growth factor.. Biochim Biophys Acta 1333(3):F179-99 PMID: 9426203
- 2. Wu JK et al.. 2024. Binding Behavior of Human Hepatoma-Derived Growth Factor on SMYD1.. J Phys Chem B 128(32):7722-7735 PMID: 39091133
- 3. Abuharbeid S et al.. 2006. The fibroblast growth factor-binding protein FGF-BP.. Int J Biochem Cell Biol 38(9):1463-8 PMID: 16324873
- 4. Lord M et al.. 2020. Better growth-factor binding aids tissue repair.. Nat Biomed Eng 4(4):368-369 PMID: 32286509
- 5. Shintani T et al.. 2024. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D(3) or eldecalcitol.. In Vitro Cell Dev Biol Anim 60(6):583-589 PMID: 38713345
- 6. Iwamoto R et al.. 2000. Heparin-binding EGF-like growth factor: a juxtacrine growth factor.. Cytokine Growth Factor Rev 11(4):335-44 PMID: 10959080
- 7. Vinante F et al.. 2013. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis.. Toxins (Basel) 5(6):1180-1201 PMID: 23888518
- 8. Pearson JJ et al.. 2022. Growth Factor Immobilization Strategies for Musculoskeletal Disorders.. Curr Osteoporos Rep 20(1):13-25 PMID: 35118607
